|
1
|
Dong Q, Li C, Che X, Qu J, Fan Y, Li X, Li
Y, Wang Q, Liu Y, Yang X and Qu X: MicroRNA-891b is an independent
prognostic factor of pancreatic cancer by targeting Cbl-b to
suppress the growth of pancreatic cancer cells. Oncotarget.
7:82338–82353. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu M, Roth A, Yu M, Morris R, Bersani F,
Rivera MN, Lu J, Shioda T, Vasudevan S, Ramaswamy S, et al: The
IGF2 intronic miR-483 selectively enhances transcription from IGF2
fetal promoters and enhances tumorigenesis. Genes Dev.
27:2543–2548. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lin Q, Ma L, Liu Z, Yang Z, Wang J, Liu J
and Jiang G: Targeting microRNAs: A new action mechanism of natural
compounds. Oncotarget. 8:15961–15970. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Xu L, Dai W, Li J, He L, Wang F, Xia Y,
Chen K, Li S, Liu T, Lu J, et al: Methylation-regulated miR-124-1
suppresses tumorigenesis in hepatocellular carcinoma by targeting
CASC3. Oncotarget. 7:26027–26041. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu CC, Lin SP, Hsu HS, Yang SH, Lin CH,
Yang MH, Hung MC and Hung SC: Suspension survival mediated by
PP2A-STAT3-Col XVII determines tumour initiation and metastasis in
cancer stem cells. Nat Commun. 7(11798)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cristóbal I, Manso R, Rincón R, Caramés C,
Senin C, Borrero A, Martínez-Useros J, Rodriguez M, Zazo S,
Aguilera O, et al: PP2A inhibition is a common event in colorectal
cancer and its restoration using FTY720 shows promising therapeutic
potential. Mol Cancer Ther. 13:938–947. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang Q, Li J, Wu W, Shen R, Jiang H, Qian
Y, Tang Y, Bai T, Wu S, Wei L, et al: Smad4-dependent suppressor
pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt
pathway in pancreatic cancer. Oncotarget. 7:11208–11222.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li X, Zhang J and Ma D: PPP2R2A binds and
dephosphorylates GFPT2 in breast cancer cells. Sheng Wu Gong Cheng
Xue Bao. 34:956–963. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
11
|
Qin Q, Wang X, Yan N, Song RH, Cai TT,
Zhang W, Guan LJ, Muhali FS and Zhang JA: Aberrant expression of
miRNA and mRNAs in lesioned tissues of Graves' disease. Cell
Physiol Biochem. 35:1934–1942. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dmitriev P, Stankevicins L, Ansseau E,
Petrov A, Barat A, Dessen P, Robert T, Turki A, Lazar V, Labourer
E, et al: Defective regulation of microRNA target genes in
myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem.
288:34989–35002. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Satoh J, Kino Y and Niida S: MicroRNA-seq
data analysis pipeline to identify blood biomarkers for Alzheimer's
disease from public data. Biomarker insights. 10:21–31.
2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fortunato O, Boeri M, Moro M, Verri C,
Mensah M, Conte D, Caleca L, Roz L, Pastorino U and Sozzi G:
Mir-660 is downregulated in lung cancer patients and its
replacement inhibits lung tumorigenesis by targeting MDM2-p53
interaction. Cell Death Dis. 5(e1564)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cribbs AP, Kennedy A, Gregory B and
Brennan FM: Simplified production and concentration of lentiviral
vectors to achieve high transduction in primary human T cells. BMC
Biotechnol. 13(98)2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu
C, Li J, Wang X and Song L: Unregulated miR-96 induces cell
proliferation in human breast cancer by downregulating
transcriptional factor FOXO3a. PLoS One. 5(e15797)2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Alvarez-Fernández M, Halim VA, Aprelia M,
Laoukili J, Mohammed S and Medema RH: Protein phosphatase 2A (B55α)
prevents premature activation of forkhead transcription factor
FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated
phosphorylation. J Biol Chem. 286:33029–33036. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Forte D, Salvestrini V, Corradi G, Rossi
L, Catani L, Lemoli RM, Cavo M and Curti A: The tissue inhibitor of
metalloproteinases-1 (TIMP-1) promotes survival and migration of
acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Oncotarget. 8:2261–2274. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pestell RG: New roles of cyclin D1. Am J
Pathol. 183:3–9. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xiao F, Zhang W, Chen L, Chen F, Xie H,
Xing C, Yu X, Ding S, Chen K, Guo H, et al: MicroRNA-503 inhibits
the G1/S transition by downregulating cyclin D3 and E2F3 in
hepatocellular carcinoma. J Transl Med. 11(195)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Simerzin A, Zorde-Khvalevsky E, Rivkin M,
Adar R, Zucman-Rossi J, Couchy G, Roskams T, Govaere O, Oren M,
Giladi H and Galun E: The liver-specific microRNA-122*, the
complementary strand of microRNA-122, acts as a tumor suppressor by
modulating the p53/mouse double minute 2 homolog circuitry.
Hepatology. 64:1623–1636. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fei L and Xu H: Role of MCM2-7 protein
phosphorylation in human cancer cells. Cell Biosci.
8(43)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhao W, Cao L, Zeng S, Qin H and Men T:
Upregulation of miR-556-5p promoted prostate cancer cell
proliferation by suppressing PPP2R2A expression. Biomed
Pharmacother. 75:142–147. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shen S, Yue H, Li Y, Qin J, Li K, Liu Y
and Wang J: Upregulation of miR-136 in human non-small cell lung
cancer cells promotes Erk1/2 activation by targeting PPP2R2A.
Tumour Biol. 35:631–640. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liang WL, Cao J, Xu B, Yang P, Shen F, Sun
Z, Li WL, Wang Q and Liu F: miR-892a regulated PPP2R2A expression
and promoted cell proliferation of human colorectal cancer cells.
Biomed Pharmacother. 72:119–124. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zeng LP, Hu ZM, Li K and Xia K: miR-222
attenuates cisplatin-induced cell death by targeting the
PPP2R2A/Akt/mTOR Axis in bladder cancer cells. J Cell Mol Med.
20:559–567. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wong QW, Ching AK, Chan AW, Choy KW, To
KF, Lai PB and Wong N: MiR-222 overexpression confers cell
migratory advantages in hepatocellular carcinoma through enhancing
AKT signaling. Clin Cancer Res. 16:867–875. 2010.PubMed/NCBI View Article : Google Scholar
|
